Literature DB >> 9094169

Male breast cancer: a retrospective study with immunohistochemical analysis of hormone receptor expression.

P H Tan1, I T Sng.   

Abstract

Of twenty-two cases of breast carcinoma diagnosed in men in Singapore since 1969, 17 were classified as infiltrative ductal carcinoma, three as papillary and one as mucinous carcinoma. The remaining case could not be classified and further immunohistochemical workup suggested the possibility of metastasis from an occult prostatic primary. Fourteen cases that were staged revealed a majority of seven (50%) cases in Stage II, with three (21%) Stage I, one (8%) Stage III and three (21%) Stage IV cases. Estrogen and progesterone receptor (ER and PR) expression was determined in 20 cases using immunohistochemical staining of archival paraffin embedded tissue blocks, which demonstrated ER and PR positivity in 65% of the cases respectively.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094169     DOI: 10.1080/00313029700169444

Source DB:  PubMed          Journal:  Pathology        ISSN: 0031-3025            Impact factor:   5.306


  4 in total

1.  Hormone receptor expression in male breast cancers.

Authors:  Ab Akosa; S Van Norden; Y Tettey
Journal:  Ghana Med J       Date:  2005-03

2.  Occult breast cancers manifesting as axillary lymph node metastasis in men: a two-case report.

Authors:  Sung Mo Hur; Dong Hui Cho; Se Kyung Lee; Min-Young Choi; Soo Youn Bae; Min Young Koo; Sangmin Kim; Seok-Jin Nam; Jeong Eon Lee; Jung-Hyun Yang
Journal:  J Breast Cancer       Date:  2012-09-28       Impact factor: 3.588

Review 3.  Papillary carcinoma of the breast in a male patient with a treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy: a case report and review of the literature.

Authors:  Walid E Khalbuss; Abiy Ambaye; Steve Goodison; Asif Loya; Shahla Masood
Journal:  Diagn Cytopathol       Date:  2006-03       Impact factor: 1.582

4.  A retrospective analysis of survival and prognostic factors of male breast cancer from a single center.

Authors:  Amr A Soliman; Adel T Denewer; Wael El-Sadda; Ali H Abdel-Aty; Basel Refky
Journal:  BMC Cancer       Date:  2014-03-28       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.